National Comprehensive Cancer Network



Educational Events & Programs

NCCN 5th Annual Congress: Hematologic Malignancies™

Supporting Organizations

The educational portion of this congress is supported by educational grants from:

  • Allos Therapeutics, Inc.
  • ARIAD Pharmaceuticals
  • Bristol-Myers Squibb
  • Celgene Corporation
  • Centocor Ortho Biotech
  • Eisai Inc.
  • Genentech BioOncology and Biogen Idec
  • Merck
  • Millennium Pharmaceuticals, Inc.
  • Novartis Oncology
  • Otsuka America Pharmaceutical, Inc.
  • Pfizer
  • sanofi-aventis
  • Sigma-Tau Pharmaceuticals, Inc.

 

This activity is supported by an educational donation provided by:

  • Amgen

 


Support was solicited from a broad array of managed care and pharma/biotech companies and organizations. This list will be updated as additional supporters are confirmed.

The National Comprehensive Cancer Network® (NCCN®) appreciates that supporting companies recognize NCCN®’s need for autonomy in the development of the content of NCCN® resources. All NCCN Content is produced completely independently.